Curated News: Medical Meetings

• share
• favorite_border

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute, will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care

• share
• favorite_border

Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances across the full spectrum of cancer research at the American Association for Cancer Research (AACR) Annual Meeting 2023 from April 14-19 in Orlando, Florida.

• share
• favorite_border

The American Association of Neurological Surgeons (AANS) Annual Meeting will be the first ever to showcase the late-breaking abstract “Decompressive Craniectomy vs Craniotomy for Traumatic Acute Subdural Hematoma” Sunday, April 23, at 9:10 am-9:18 am, during Plenary Session ll.

• share
• favorite_border

A new study sheds light on an understudied aspect of today’s opioid crisis: What happens to the cardiovascular health of babies exposed to opioids in the womb.

• share
• favorite_border

New smart-drug treatment options for pancreatic cancer, immuno-oncology treatments and real-time immune-monitoring strategies are among the research topics to be presented by investigators at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) at the American Association for Cancer Research (AACR) annual meeting held April 14-19 at the Orange County Convention Center in Orlando, Florida.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the American Association for Cancer Research (AACR) Annual Meeting 2023.

• share
• favorite_border

American Cancer Society researchers are headed to Orlando, Florida this week for the annual meeting of the American Association of Cancer Research.

• share
• favorite_border

The NCCN 2023 Annual Conference took place in-person in Orlando and virtually, with a particular focus on human connection. That connection was underscored with more than 2,000 registrants from across the continuum of cancer care, including approximately 1,000 who returned in-person for the first time since 2019. Educational sessions highlighted the importance of ensuring care meets the latest standards while also rejecting a one-size-fits-all approach.

• share
• favorite_border

• share
• favorite_border

The American Association of Cancer Research (AACR) will honor two investigators from St. Jude Children’s Research Hospital for their research contributions. Melissa Hudson, M.D., director of the Cancer Survivorship Division and Jun J. Yang, Ph.D., vice-chair of Pharmacy and Pharmaceutical Sciences

• share
• favorite_border

Cedars-Sinai Cancer oncologists and researchers are available to comment on late-breaking topics and research throughout the American Association for Cancer Research (AACR) Annual Meeting 2023, happening April 14-19 in Orlando.

• share
• favorite_border

Complimentary press passes are now available for NUTRITION 2023, the annual flagship meeting of the American Society for Nutrition. Join us July 22-25 in Boston to hear about the latest developments in nutrition research, practice, and policy.

• share
• favorite_border

The American Association of Neurological Surgeons (AANS) Annual Meeting is known for showcasing the latest research, science and technology, and this year is no exception in Los Angeles. The late-breaking abstract “An Intracortical Speech BCI for High-Performance Brain-to-Text Communication” will be shared during the Opening Session, Friday, April 21, at 5:30 pm-5:38 pm, PST.

• share
• favorite_border

Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) physicians and scientists are presenting research studies at the 2023 American Association for Cancer Research (AACR) Annual Meeting at the Orange County Convention Center in Orlando, Florida, April 14 to 19th.

• share
• favorite_border

A June 13-14 gathering of scientific and regulatory experts at the National Press Club

• share
• favorite_border

A new Cornell University-led study suggests that if artificial intelligence tools can counsel a doctor like a colleague – pointing out relevant research that supports the decision – then doctors can better weigh the merits of the recommendation.

• share
• favorite_border

A significant clinical trial under the direction of Michael Kappelman, MD, MPH, professor of pediatrics at UNC School of Medicine, found that patients receiving the tumor necrosis factor inhibitor adalimumab combined with a low dose of methotrexate, a second immunosuppressant, did better than those treated with infliximab alone. Patients who received infliximab, another tumor necrosis factor inhibitor, had similar outcomes with or without methotrexate.

• share
• favorite_border

Recordings of media briefings will be posted by 10 a.m. Eastern Time on each day. Watch recorded media briefings at: www.acs.org/ACSSpring2023briefings.

• share
• favorite_border

Imagine getting the benefits of gastric bypass surgery without going under the knife. A new class of potential treatments has done that in lab animals, reducing weight dramatically and lowering blood glucose without side effects, scientists report. They will present their results at ACS Spring 2023.

• share
• favorite_border

A new study has revealed insights into how cells sense and respond to the weightlessness experienced in space. The information could be useful for keeping astronauts healthy on future space missions.

• share
• favorite_border

New research has revealed important information about how aspirin works. The new findings could pave the way to safer aspirin alternatives and might also have implications for improving cancer immunotherapies.

• share
• favorite_border

The fruit of the cocklebur plant, which grows worldwide and is often considered a noxious weed, has antioxidant and anti-inflammatory components that could make it useful as a skin protectant, according to new research.

• share
• favorite_border

Cedars-Sinai and BlackDoctor.org will host a virtual community conversation about the importance of increasing diverse representation in medical research.

• share
• favorite_border

Scientists report using a single-atom-thick nanomaterial to build a device that can simultaneously detect the presence of the viruses that cause COVID-19 and the flu — at much lower levels and much more quickly than conventional tests for either. They will present their results at ACS Spring 2023.

• share
• favorite_border

Naloxone can reverse potentially fatal overdoses, but it’s less effective against powerful fentanyl. To develop alternatives, researchers are looking to a component of marijuana, CBD. They will present their results at ACS Spring 2023.

• share
• favorite_border

Growing concerns over the potential health effects of exposure to phthalates have led to a search for safer alternatives. Researchers found that the chemical acetyl tributyl citrate (ATBC) might not be the best replacement.

• share
• favorite_border

A new study found that people who are currently suffering or face a high risk of post-traumatic stress disorder show particular patterns in four biomarkers measurable with a simple blood test.

• share
• favorite_border

For the first time, researchers have developed a form of the omega-3 fatty acid docosahexaenoic acid (DHA) that is capable of crossing into the eye’s retina to ward off visual declines related to Alzheimer’s disease, diabetes and other disorders.

• share
• favorite_border

The results of two clinical trials, presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer, showcased adding immunotherapy to standard chemotherapy resulted in significantly longer progression-free survival (PFS) among patients with advanced or recurrent endometrial cancer (EC).

• share
• favorite_border

In an effort to improve understanding of pulmonary fibrosis (PF) and interstitial lung disease (ILD), data from the PFF Registry is presenting researchers with opportunities to accelerate understanding of PF and ILD to improve patient outcomes.

• share
• favorite_border

Needles are an uncomfortable but necessary aspect of vaccination. But today, scientists report steps toward an alternative, relatively painless method that can deliver biological materials to cells by “shooting” them in with air. They will present their results at ACS Spring 2023.

• share
• favorite_border

Researchers examined how a country’s number of published 3D protein structures for coronaviruses correlated with its economic output and population. The findings reveal important insights into how different countries' research establishments respond to disease outbreaks.

• share
• favorite_border

After resolving missing data burdens, the ENGOT-OV16/NOVA (NCT01847274) study data shows no difference in overall survival for platinum-sensitive recurrent ovarian cancer (PSROC) patients who received PARP inhibitor niraparib maintenance therapy (MT) and those who did not. Results from the trial were presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer by Ursula Matulonis, MD, of the Dana-Farber Cancer Institute.

• share
• favorite_border

Researchers examined the material properties of a thin surface barrier called the glycocalyx with unprecedented resolution, revealing information that could help improve current cell-based cancer immunotherapies.

• share
• favorite_border

A new study identified a compound that prevents C. diff infection. Researchers are now using this compound to develop new drug candidates that might eventually offer a way to prevent serious C. diff infections.

• share
• favorite_border

Time-related and financial burdens are detrimental to gynecologic cancer patient and survivor quality of life (QOL), according to two research studies presented yesterday and today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.

• share
• favorite_border

Black women and others with curly or kinky hair encounter a confusing array of haircare options. Now, scientists are identifying hair properties that could help users pick the perfect product and achieve consistent results. They will present their results at ACS Spring 2023.

• share
• favorite_border

Clinical trial participation was associated with improved overall survival (OS) compared to standard of care therapy among women with platinum-resistant epithelial ovarian cancer (EOC), according to a research study presented today at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.

• share
• favorite_border

A new study examining the gene expression of gut microbes suggests that the heart-healthy benefits of walnuts may be linked to beneficial changes in the mix of microbes found in our gut.

• share
• favorite_border

Administering PARP inhibitor (PARPi) olaparib prior to surgical intervention and chemotherapy in ovarian cancer patients – a new approach – is feasible and resulted in favorable surgical options, managed adverse events, and positive health outcomes, according to results from the Neoadjuvant Olaparib Window (NOW) Trial presented today by Shannon Westin, MD et al. at the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer.

• share
• favorite_border

Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”

• share
• favorite_border

Post-acute sequelae SARS-CoV-2 infection (PASC), also known as long-haul COVID-19, is positively associated with posttraumatic stress disorder (PTSD), says new research presented at Physiatry ’23, the Association of Academic Physiatrists (AAP) annual meeting.

• share
• favorite_border

There are limited standardized translations of the National Institutes of Health Stroke Scale (NIHSS) as well as several barriers to using interpreter services within medical institutions, according to new research presented at Physiatry ’23, the Association of Academic Physiatrists (AAP) annual meeting.

• share
• favorite_border

New research presented at Physiatry '23

• share
• favorite_border

Women with limb loss have unique physical and psychosocial needs, meaning providers treating this population must adapt their healthcare delivery approach, says new research presented at Physiatry ’23, the Association of Academic Physiatrists (AAP) annual meeting.